Literature DB >> 8524126

Biological assays for Ras transformation.

G J Clark1, A D Cox, S M Graham, C J Der.   

Abstract

The rodent fibroblast systems described above have provided sensitive and rapid biological assays to characterize the properties of normal and mutated Ras proteins. Furthermore, these assays have provided in vitro systems to measure the ability of other cellular components to modulate Ras signal transduction and transformation. However, while these assays provide an excellent measure of Ras-transforming activity, the fact that these cells are of fibroblastic origin, and can be transformed by a single hit, indicates that caution should be used in extrapolating observations from NIH 3T3 transformation assays to the situation in human tumors. Therefore, using human epithelial cell-based assays that more closely approximate the cell types where mutated ras alleles are most frequently detected may provide more realistic assays for examining the biochemical and biological consequences of aberrant Ras function in human tumors. Nevertheless, despite these cautions, these rodent transformation assays will continue to be the best and most widely applied assays for Ras biological activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524126     DOI: 10.1016/s0076-6879(95)55042-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  66 in total

1.  Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activation.

Authors:  I P Whitehead; Q T Lambert; J A Glaven; K Abe; K L Rossman; G M Mahon; J M Trzaskos; R Kay; S L Campbell; C J Der
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  The insert region of Rac1 is essential for membrane ruffling but not cellular transformation.

Authors:  A E Karnoub; C J Der; S L Campbell
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  Critical but distinct roles for the pleckstrin homology and cysteine-rich domains as positive modulators of Vav2 signaling and transformation.

Authors:  Michelle A Booden; Sharon L Campbell; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  The CRAL/TRIO and GOLD domain protein TAP-1 regulates RAF-1 activation.

Authors:  Kenneth G Johnson; Kerry Kornfeld
Journal:  Dev Biol       Date:  2010-03-15       Impact factor: 3.582

5.  Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity.

Authors:  Emily J Chenette; Natalia Y Mitin; Channing J Der
Journal:  Mol Biol Cell       Date:  2006-04-26       Impact factor: 4.138

6.  CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.

Authors:  Songyun Zhu; Kyungsil Yoon; Esta Sterneck; Peter F Johnson; Robert C Smart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

7.  Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.

Authors:  Duo Zheng; Yong-Yeon Cho; Andy T Y Lau; Jishuai Zhang; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

8.  CDC42 and FGD1 cause distinct signaling and transforming activities.

Authors:  I P Whitehead; K Abe; J L Gorski; C J Der
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

9.  Mitogenic and oncogenic properties of the small G protein Rap1b.

Authors:  D L Altschuler; F Ribeiro-Neto
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1.

Authors:  Rika Tanaka; Yutaka Seki; Yohei Saito; Sadahiro Kamiya; Motomichi Fujita; Hiroaki Okutsu; Takuya Iyoda; Tatsuya Takai; Toshiyuki Owaki; Hirofumi Yajima; Junichi Taira; Ryo Hayashi; Hiroaki Kodama; Takuya Matsunaga; Fumio Fukai
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.